Pharmaceutics International Inc. (Pii), a provider of pharmaceutical development and manufacturing services, has launched its Accelevate Early Development Platform, which is designed to accelerate the preparation of Investigational New Drug (IND) submissions, offering small to mid-sized pharmaceutical companies the ability to reach IND readiness in 100 days for aseptic products.   The Accelevate platform addresses a critical need in the pharmaceutical industry, where the pressure to reduce tim...